---
title: "广汽联合多方成立广东慧仑科技 涉多项机器人业务"
description: "由广汽集团及广州仑步投资合伙企业等共同持股广东慧仑科技近日成立，注册资本 8,302 万元人民币。该公司经营范围涵盖服务消费机器人销售、制造，特殊作业机器人制造，工业机器人销售及智能机器人研发等。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/276020418.md"
published_at: "2026-02-15T23:29:16.000Z"
---

# 广汽联合多方成立广东慧仑科技 涉多项机器人业务

> 由广汽集团及广州仑步投资合伙企业等共同持股广东慧仑科技近日成立，注册资本 8,302 万元人民币。该公司经营范围涵盖服务消费机器人销售、制造，特殊作业机器人制造，工业机器人销售及智能机器人研发等。

由广汽集团 (02238.HK) 及广州仑步投资合伙企业等共同持股广东慧仑科技近日成立，注册资本 8,302 万元人民币。该公司经营范围涵盖服务消费机器人销售、制造，特殊作业机器人制造，工业机器人销售及智能机器人研发等。

### Related Stocks

- [601238.CN - 广汽集团](https://longbridge.com/zh-CN/quote/601238.CN.md)
- [02238.HK - 广汽集团](https://longbridge.com/zh-CN/quote/02238.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 23:43 ETDie innovativen Sicherheits- und hocheffizienten Antriebsstränge von GAC finden weltweite Anerkennung | GAC is gaining global recognition for its innovative and efficient drivetrains amidst the rapidly changing automotive in | [Link](https://longbridge.com/zh-CN/news/275994919.md) |
| 09:15 ETGAC's Innovative Safety and High-Efficiency Powertrain Win Global Recognition | GAC has gained global recognition for its innovative safety and high-efficiency powertrain technologies in the rapidly t | [Link](https://longbridge.com/zh-CN/news/275913551.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/zh-CN/news/276113491.md) |
| Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | Nomura Adjusts CSPC Pharmaceutical Group's Price Target to HK$12.04 From HK$9.11, Keeps at Buy | [Link](https://longbridge.com/zh-CN/news/276056763.md) |
| Infobip Recognized as RCS for Business Leader by Juniper Research | Infobip has been recognized as the top Established Leader in the Juniper Research RCS for Business 2026 Leaderboard, cel | [Link](https://longbridge.com/zh-CN/news/276322352.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
